Stocks finished a strong week higher on optimism for a potential coronavirus vaccine and the reopening of the U.S. economy
Stocks finished a strong week higher as optimism for a potential coronavirus vaccine and the reopening of the U.S. economy won out over renewed U.S.-China geopolitical tensions and the ongoing deterioration of the U.S. labor market.
Stocks posted weekly losses as declining economic conditions and rising trade-tension risk weighed on sentiment
Stocks posted weekly losses as declining economic conditions, elevated volatility and rising trade-tension risk weighed on sentiment. Nonetheless, markets partially recovered Friday as April industrial production and May manufacturing and consumer sentiment came in better than expected.
Stocks posted a week of solid gains as markets focused on an April jobs report that wasn’t as bad as feared, expectations of continued fiscal and monetary policy support and signs of easing U.S.–China trade tensions.
U.S. Stocks finished on a positive note Friday, though down for the week as a rally in the Technology sector couldn’t beat out Monday’s historic WTI oil-price collapse.
U.S. Stocks finished higher for the second straight week, as investor optimism rode high on plans for some states to begin the process of reopening their economies and encouraging reports of potential COVID-19 treatments.
Global stock markets rallied after the Federal Reserve announced $2.3 trillion of credit to backstop the economy, boosting total U.S. government monetary and fiscal support to roughly $4 trillion.
U.S. stocks lost ground for the week as fallout from the coronavirus pandemic impacted economic reports
CBOE volatility declined as the outlook, while grim, at least grew clearer.
The major global equity markets posted strong gains during a rollercoaster week.